vs

Side-by-side financial comparison of Marvell Technology, Inc. (MRVL) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

Marvell Technology, Inc. is the larger business by last-quarter revenue ($2.2B vs $1.5B, roughly 1.5× BeOne Medicines Ltd.). Marvell Technology, Inc. runs the higher net margin — 17.9% vs 4.4%, a 13.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 22.1%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 38.2%).

Marvell Technology, Inc. is an American company, headquartered in Santa Clara, California, which develops and produces semiconductors and related technology. Founded in 1995, the company had more than 6,500 employees as of 2024, with over 10,000 patents worldwide, and an annual revenue of $5.5 billion for fiscal 2024.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

MRVL vs ONC — Head-to-Head

Bigger by revenue
MRVL
MRVL
1.5× larger
MRVL
$2.2B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+10.8% gap
ONC
32.8%
22.1%
MRVL
Higher net margin
MRVL
MRVL
13.4% more per $
MRVL
17.9%
4.4%
ONC
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
38.2%
MRVL

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
MRVL
MRVL
ONC
ONC
Revenue
$2.2B
$1.5B
Net Profit
$396.1M
$66.5M
Gross Margin
51.7%
90.5%
Operating Margin
66.5%
12.4%
Net Margin
17.9%
4.4%
Revenue YoY
22.1%
32.8%
Net Profit YoY
143.8%
EPS (diluted)
$0.46
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVL
MRVL
ONC
ONC
Q1 26
$2.2B
Q4 25
$2.1B
$1.5B
Q3 25
$2.0B
$1.4B
Q2 25
$1.9B
$1.3B
Q1 25
$1.8B
$1.1B
Q4 24
$1.5B
$1.1B
Q3 24
$1.3B
$1.0B
Q2 24
$1.2B
$929.2M
Net Profit
MRVL
MRVL
ONC
ONC
Q1 26
$396.1M
Q4 25
$1.9B
$66.5M
Q3 25
$194.8M
$124.8M
Q2 25
$177.9M
$94.3M
Q1 25
$200.2M
$1.3M
Q4 24
$-676.3M
$-151.9M
Q3 24
$-193.3M
$-121.3M
Q2 24
$-215.6M
$-120.4M
Gross Margin
MRVL
MRVL
ONC
ONC
Q1 26
51.7%
Q4 25
51.6%
90.5%
Q3 25
50.4%
86.1%
Q2 25
50.3%
87.5%
Q1 25
50.5%
85.2%
Q4 24
23.0%
85.8%
Q3 24
46.2%
83.0%
Q2 24
45.5%
85.1%
Operating Margin
MRVL
MRVL
ONC
ONC
Q1 26
66.5%
Q4 25
17.2%
12.4%
Q3 25
14.5%
11.5%
Q2 25
14.3%
6.7%
Q1 25
12.9%
1.0%
Q4 24
-46.4%
-7.0%
Q3 24
-7.9%
-12.0%
Q2 24
-13.1%
-11.5%
Net Margin
MRVL
MRVL
ONC
ONC
Q1 26
17.9%
Q4 25
91.7%
4.4%
Q3 25
9.7%
8.8%
Q2 25
9.4%
7.2%
Q1 25
11.0%
0.1%
Q4 24
-44.6%
-13.5%
Q3 24
-15.2%
-12.1%
Q2 24
-18.6%
-13.0%
EPS (diluted)
MRVL
MRVL
ONC
ONC
Q1 26
$0.46
Q4 25
$2.20
$0.05
Q3 25
$0.22
$0.08
Q2 25
$0.20
$0.06
Q1 25
$0.23
$0.00
Q4 24
$-0.78
$-0.10
Q3 24
$-0.22
$-0.09
Q2 24
$-0.25
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVL
MRVL
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$2.6B
$4.5B
Total DebtLower is stronger
$4.5B
$836.4M
Stockholders' EquityBook value
$14.3B
$4.4B
Total Assets
$22.3B
$8.2B
Debt / EquityLower = less leverage
0.31×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVL
MRVL
ONC
ONC
Q1 26
$2.6B
Q4 25
$2.7B
$4.5B
Q3 25
$1.2B
$4.0B
Q2 25
$885.9M
$2.8B
Q1 25
$948.3M
$2.5B
Q4 24
$868.1M
$2.6B
Q3 24
$808.7M
$2.7B
Q2 24
$847.7M
$2.6B
Total Debt
MRVL
MRVL
ONC
ONC
Q1 26
$4.5B
Q4 25
$4.5B
$836.4M
Q3 25
$4.5B
Q2 25
$4.2B
Q1 25
$4.1B
Q4 24
$4.1B
Q3 24
$4.1B
Q2 24
$4.1B
Stockholders' Equity
MRVL
MRVL
ONC
ONC
Q1 26
$14.3B
Q4 25
$14.1B
$4.4B
Q3 25
$13.4B
$4.1B
Q2 25
$13.3B
$3.8B
Q1 25
$13.4B
$3.5B
Q4 24
$13.4B
$3.3B
Q3 24
$14.2B
$3.4B
Q2 24
$14.5B
$3.4B
Total Assets
MRVL
MRVL
ONC
ONC
Q1 26
$22.3B
Q4 25
$21.6B
$8.2B
Q3 25
$20.6B
$7.6B
Q2 25
$20.0B
$6.3B
Q1 25
$20.2B
$5.8B
Q4 24
$19.7B
$5.9B
Q3 24
$20.3B
$5.8B
Q2 24
$20.5B
$5.7B
Debt / Equity
MRVL
MRVL
ONC
ONC
Q1 26
0.31×
Q4 25
0.32×
0.19×
Q3 25
0.33×
Q2 25
0.32×
Q1 25
0.30×
Q4 24
0.31×
Q3 24
0.29×
Q2 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVL
MRVL
ONC
ONC
Operating Cash FlowLast quarter
$373.7M
$417.3M
Free Cash FlowOCF − Capex
$379.8M
FCF MarginFCF / Revenue
25.4%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
0.94×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVL
MRVL
ONC
ONC
Q1 26
$373.7M
Q4 25
$582.3M
$417.3M
Q3 25
$461.6M
$402.6M
Q2 25
$332.9M
$263.6M
Q1 25
$514.0M
$44.1M
Q4 24
$536.3M
$75.2M
Q3 24
$306.4M
$188.4M
Q2 24
$324.5M
$-95.6M
Free Cash Flow
MRVL
MRVL
ONC
ONC
Q1 26
Q4 25
$508.8M
$379.8M
Q3 25
$414.1M
$354.5M
Q2 25
$214.1M
$219.8M
Q1 25
$444.1M
$-12.3M
Q4 24
$461.3M
$-17.3M
Q3 24
$258.2M
$54.7M
Q2 24
$233.0M
$-205.5M
FCF Margin
MRVL
MRVL
ONC
ONC
Q1 26
Q4 25
24.5%
25.4%
Q3 25
20.6%
25.1%
Q2 25
11.3%
16.7%
Q1 25
24.4%
-1.1%
Q4 24
30.4%
-1.5%
Q3 24
20.3%
5.5%
Q2 24
20.1%
-22.1%
Capex Intensity
MRVL
MRVL
ONC
ONC
Q1 26
Q4 25
3.5%
2.5%
Q3 25
2.4%
3.4%
Q2 25
6.3%
3.3%
Q1 25
3.8%
5.0%
Q4 24
4.9%
8.2%
Q3 24
3.8%
13.3%
Q2 24
7.9%
11.8%
Cash Conversion
MRVL
MRVL
ONC
ONC
Q1 26
0.94×
Q4 25
0.31×
6.28×
Q3 25
2.37×
3.22×
Q2 25
1.87×
2.79×
Q1 25
2.57×
34.71×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVL
MRVL

Data center$1.7B74%
Communications and other$567.4M26%

ONC
ONC

Segment breakdown not available.

Related Comparisons